Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
DetailsOverviewExplorerRelated

Final Response Letter from FDA CDER to The WhiteOak Group, LLC (on behalf of Hybio Pharmaceutical Co., Ltd.)

FDA-2025-P-7376-0009Other
Comments
0
Awaiting comments
Deadline
--
Net supportiSupport minus oppose · campaigns included
—
Document

Details

The document's own metadata, straight from the source system.

Title
Final Response Letter from FDA CDER to The WhiteOak Group, LLC (on behalf of Hybio Pharmaceutical Co., Ltd.)
Posted
Jul 16, 2026
Comment period
Jul 16, 2026 – ?
Agency
Food and Drug Administration (FDA)
Topics
View on regulations.gov ↗
Analysis

Overview

No comments yet.

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Filter:

No comments match.